S. Ross

Insulin stimulates cell surface aminopeptidase activity toward vasopressin in adipocytes

John J. Herbst, S. Ross, Hazel M. Scott et al. · American Journal of Physiology-Endocrinology and Metabolism · 1997 · 98 citations

Insulin Signaling, Gastrointestinal Peptide Hormone, Metabolic Syndrome +17

A comparative study of insulin lispro and human regular insulin in patients with type 2 diabetes mellitus and secondary failure of oral hypoglycemic agents.

S. Ross, Bernard Zinman, R V Campos et al. · PubMed · 2001 · 67 citations

The safety and efficacy of adding once‐daily insulin detemir to oral hypoglycaemic agents in patients with type 2 diabetes in a clinical practice setting in 10 countries

Kamlesh Khunti, Salvatore Caputo, Grzegorz Dzida et al. · Diabetes Obesity and Metabolism · 2012 · 51 citations

Efficacy and safety of empagliflozin twice daily versus once daily in patients with type 2 diabetes inadequately controlled on metformin: a 16‐week, randomized, placebo‐controlled trial

S. Ross, Claus Thamer, Jessica Cescutti et al. · Diabetes Obesity and Metabolism · 2015 · 48 citations · Full text

Empagliflozin Twice Daily, Metabolic Syndrome, Diabetes Management +11

The mind’s scalpel in surgical education: a randomised controlled trial of mental imagery

Roxana Geoffrion, JB Gebhart, Yashika Dooley et al. · BJOG An International Journal of Obstetrics & Gynaecology · 2012 · 42 citations · Full text